The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
The remaining barriers between fundamental and applied non-clinical and clinical sciences have to be broken down and collaboration has to take place with all stakeholders in the field of drug-intervention design and development. This allows the development of personalized treatment within the next decade, which will have an actual personal and societal impact. GUIDE is a collaboration between the University Medical Center Groningen (UMCG) and the Faculty of Science and Engineering at the University of Groningen (UG).
It is best to provide each of our patients with tailor-made treatments. GUIDE covers all aspects of the drug-intervention life cycle, from its design and development to its use in daily clinical practice.
GUIDE conducts combined drug research aimed at developing an improved therapy model for every individual patient. The institute improves the processes of:
GUIDE integrates omics and big data sciences to improve target finding.
GUIDE accelerates drug design and development by using rapid drug discovery technology and advanced, more humanized methods for candidate screening and selection.
GUIDE’s clinical implementation activities focus on:
Research on small therapeutic molecules will be extended towards biopharmaceuticals, gene-based products, and interactions with lifestyle changes.
University Medical Center Groningen (UMCG)
P.O. Box 196
9700 AD Groningen